Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 8/26/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 956K
-160.76x13.34x-181.56x-.--% 38.35B
23.15x2.05x12.08x0.94% 25.01B
17.83x1.37x7.77x4.91% 7.58B
327.08x - - - 5.02B
51.21x9.48x32.64x0.97% 3.33B
-51.61x - - -.--% 1.96B
-19.46x - - - 1.93B
33.86x1.7x12.96x1.51% 1.9B
13.35x1.37x5.38x5.82% 1.83B
Average 26.07x 4.88x -18.45x 2.02% 8.69B
Weighted average by Cap. -42.44x 7.82x -82.78x 0.97%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited